发明名称 |
THERAPEUTIC OR PREVENTIVE AGENT FOR MEIBOMIAN GLAND DYSFUNCTION OR MEIBOMIAN GLAND BLOCKAGE |
摘要 |
The objective of the present invention is to provide a new medicinal use of clarithromycin. The present invention is a therapeutic agent or a preventive agent for meibomian gland dysfunction or meibomian gland blockage and comprises clarithromycin as an active ingredient. The dosage form is preferably an eye drop or eye ointment. |
申请公布号 |
US2017071852(A1) |
申请公布日期 |
2017.03.16 |
申请号 |
US201615363583 |
申请日期 |
2016.11.29 |
申请人 |
Santen Pharmaceutical Co., Ltd. |
发明人 |
KIDO Kazutaka;NAGANO Takashi |
分类号 |
A61K9/00;A61K31/7048 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for therapy of meibomian gland dysfunction that is a condition where a diffuse abnormality of the function of the meibomian glands is induced by various causes, the method comprising administration of clarithromycin to a subject in need thereof. |
地址 |
Osaka JP |